The significant elevation of GRP78 in patients with more pronounced inflammation (higher CRP), coagulopathy (higher D-dimer), and respiratory compromise (lower oxygen saturation) reinforces its potential as a clinically relevant biomarker. This evidence concerns the gene HSPA5 and blood coagulation disease.